Immunohistochemical expression of estrogens and progesterone receptors in carcinoma ex pleomorphic adenoma-undifferentiated and adenocarcinoma types

Medicina Oral, Patologia Oral y Cirugia Bucal

Volumn 15, Issue 3, 2010, Pages

  Tarakji, Bassel ^a   Nassani, Mohammad Z ^a   Sloan, Philip ^b  

^a UNIVERSITY OF ALEPPO   (Syrian Arab Republic)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Estrogens receptor; Pleomorphic salivary adenoma; Progesterone receptor; Salivary carcinoma

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PLEOMORPHIC ADENOMA; SALIVARY GLAND CARCINOMA; STAINING;

ADENOCARCINOMA; ADENOMA, PLEOMORPHIC; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SALIVARY GLAND NEOPLASMS;

EID: 77952306356     PISSN: 16984447     EISSN: 16986946     Source Type: Journal    
DOI: 10.4317/medoral.15.e432     Document Type: Article

References (20)

1. Olejniczak I, Kozłowski Z, Dabrowska K, Lukomski M. [Tumors of the parotid gland - management and results of surgical treatment]. Otolaryngol Pol. 2008;62:446-450
2. Do Prado RF, Consolaro A, Taveira LA. Expression of betacatenin in carcinoma in pleomorphic adenoma, pleomorphic adenoma and normal salivary gland: an immunohistochemical study. Med Oral Patol Oral Cir Bucal. 2006;11:E247-51.
3. Rodríguez-Fernández J, Mateos-Micas M, Martínez- Tello FJ, Berjón J, Montalvo JJ, Forteza-González G, et al. Metastatic benign pleomorphic adenoma. Report of a case and review of the literature. Med Oral Patol Oral Cir Bucal. 2008;13:E193-6.
4. Bretschneider N, Brand H, Miller N, Lowery AJ, Kerin MJ, Gannon F, et al. Estrogen induces repression of the breast cancer and salivary gland expression gene in an estrogen receptor alpha-dependent manner. Cancer Res. 2008;68:106-114 (Pubitemid 351380111)
5. Ma CX, Sanchez CG, Ellis MJ. Predicting endocrine therapy responsiveness in breast cancer. Oncology (Williston Park). 2009;23:133-142
6. Pertschuk LP, Eisenberg KB, Carter AC, Feldman JG. Immunohistologic localization of estrogen receptors in breast cancer with monoclonal antibodies. Correlation with biochemistry and clinical endocrine response. Cancer. 1985;55:1513-1518
7. Singh Y, Sayami P, Sayami G, Nakagawa H, Koreeda T, Hatano T, et al. Nepalese breast cancer in relation to reproductive factors: comparison between Nepalese and Japanese cases. Anticancer Res. 2002;22:319-323 (Pubitemid 34475319)
8. Dimery IW, Jones LA, Verjan RP, Raymond AK, Goepfert H, Hong WK. Estrogen receptors in normal salivary gland and salivary gland carcinoma. Arch Otolaryngol Head Neck Surg. 1987;113:1082-1085 (Pubitemid 18058225)
9. Driscoll MS, Grant-Kels JM. Estrogen receptor expression in cutaneous melanoma. Arch Dermatol. 2009;145:73-75
10. Ripoll C, Ropero AB, Alonso-Magdalena P, Quesada I, Fuentes E, Nadal A. Rapid regulation of pancreatic alpha- and beta- cell signalling systems by estrogens. Infect Disord Drug Targets. 2008;8:61-64 (Pubitemid 351663638)
11. Birsak CA, Janssen PJ, Van Vroonhoven CC, Peterse JL, Van der Kwast TH. Sex steroid receptor expression in 'carcinoid' tumours of the breast. Breast Cancer Res Treat. 1996;40:243-249
12. Mai KT, Teo I, Belanger EC, Robertson SJ, Marginean EC, Islam S. Progesterone receptor reactivity in renal oncocytoma and chromophobe renal cell carcinoma. Histopathology. 2008;52:277-282 (Pubitemid 351208057)
13. Nagao K, Matsuzaki O, Saiga H, Sugano I, Shigematsu H, Kaneko T, et al. Histopathologic studies on carcinoma in pleomorphic adenoma of the parotid gland. Cancer. 1981;48:113-121 (Pubitemid 11064387)
14. Azuma M, Kasai Y, Tamatani T, Sato M. Involvement of p53 mutation in the development of human salivary gland pleomorphic adenomas. Cancer Lett. 1992;65:61-71.
15. Yamamoto Y, Kishimoto Y, Virmani AK, Smith A, Vuitch F, Albores-Saavedra J, et al. Mutations associated with carcinomas arising from pleomorphic adenomas of the salivary glands. Hum Pathol. 1996;27:782-786 (Pubitemid 26287218)
16. Yamamoto Y, Kishimoto Y, Wistuba II, Virmani AK, Vuitch F, Gazdar AF, et al. DNA analysis at p53 locus in carcinomas arising from pleomorphic adenomas of salivary glands: comparison of molecular study and p53 immunostaining. Pathol Int. 1998;48:265-272 (Pubitemid 28328306)
17. Shick PC, Riordan GP, Foss RD. Estrogen and progesterone receptors in salivary gland adenoid cystic carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;80:440-444
18. Dori S, Trougouboff P, David R, Buchner A. Immunohistochemical evaluation of estrogen and progesterone receptors in adenoid cystic carcinoma of salivary gland origin. Oral Oncol. 2000;36:450-453 (Pubitemid 30645980)
19. Miller AS, Hartman GG, Chen SY, Edmonds PR, Brightman SA, Harwick RD. Estrogen receptor assay in polymorphous low-grade adenocarcinoma and adenoid cystic carcinoma of salivary gland origin. An immunohistochemical study. Oral Surg Oral Med Oral Pathol. 1994;77:36-40.
20. Nasser SM, Faquin WC, Dayal Y. Expression of androgen, estrogen, and progesterone receptors in salivary gland tumors. Frequent expression of androgen receptor in a subset of malignant salivary gland tumors. Am J Clin Pathol. 2003;119:801-806 (Pubitemid 37047840)